Actualités sur Medizin, Gesundheit

Kunstmuseum St.Gallen

2

Press Release Kunstmuseum St.Gallen | RM: Anus Horribilis

OceanCare

Clean-washing? Plastic clean-up tech not all it seems on the surface

CLEAN-UPS OR CLEAN-WASHING? Environmental organisations claim Plastic clean-up tech not all it seems on the surface LONDON/ZURICH, 6th November 2023: A new report from the Environmental Investigation Agency (EIA) and OceanCare highlights the damaging impacts of ‘quick fix’ ocean clean-up ...

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex 2022 in review: comfortable increase, significant slowdown, unexpected final spurt

Euro Airport Basel-Mulhouse-Freiburg

Summer vacation 2022: Travel at ease thanks to a good preparation

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex: Staff leasing sector recovers from impact of coronavirus in 2021

swissstaffing - Verband der Personaldienstleister der Schweiz

Flexwork: more and more highly qualified workers are in temporary work

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex - Strong Recovery in the Staff Leasing Sector: Working Hours up Almost 25% This Quarter Year-on-Year

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex - Second lockdown causes strain, but optimism for the summer

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex - Coronavirus Summary 2020: Staff Leasing Sector Slumps 14.3%

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex - A Second Wave of Coronavirus Threatens the Swiss Labor Market

Debiopharm International SA

DEBIOPHARM TO PRESENT LATE BREAKING HEAD & NECK CANCER ABSTRACT AT THE 2020 EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS

Lausanne, Switzerland (ots) - Debiopharm announces the presentation of the 3-year phase II follow-up data along with 2 posters for xevinapant (antagonist of IAP -Inhibitor of Apoptosis Proteins) and WEE1 inhibitor Debio 0123 Debiopharm, ...

MSD Merck Sharp & Dohme AG

MSD (Merck Sharp & Dohme AG) Switzerland appoints Ans Heirman, Ph.D. as the new Managing Director of MSD Switzerland, effective September 1st, 2020

Euro Airport Basel-Mulhouse-Freiburg

COVID-19 screening for passengers from countries at risk

COVID-19 screening for passengers from countries at risk From Saturday 1 August 2020, in accordance with French legislation, mandatory COVID-19 tests will be carried out at EuroAirport for all travelers from countries at risk. At present, this applies to arrivals from ...

Euro Airport Basel-Mulhouse-Freiburg

EuroAirport prepares for the return of passengers - protective masks mandatory on airport premises

EuroAirport prepares for the return of passengers – protective masks mandatory on airport premises After both France and Switzerland announced an easing of ...

MSD Merck Sharp & Dohme AG

MSD in Switzerland launches new gender-neutral parental leave policy effective February 1st, 2020

Lucerne (ots) - Following its nomination for an eight time in a row as Top Employer Switzerland, MSD (Merck Sharp & Dohme AG) is delighted to announce the introduction of a new gender-neutral parental leave policy to all its employees within ...

MSD Merck Sharp & Dohme AG

On World Cancer Day, MSD Switzerland Stands United in Support of its Patients

Lucerne (ots) - World Cancer Day every 4th of February is a global uniting movement led by the Union for International Cancer Control (UICC). MSD (Merck Sharp & Dohme) is a proud sponsor of this initiative, joining the conversation to create a groundswell of awareness and action that will enable powerful ...

MSD Merck Sharp & Dohme AG

MSD Expands Operations in Switzerland

Lucerne (ots) - - Company will open a new location in Zurich, focused on accelerating research, data and commercialization of our medicines and vaccines - Lucerne will remain the center of MSD's presence in Switzerland MSD (Merck Sharp & Dohme AG) today announced that it will establish a new office in Zurich, Switzerland, aimed at accelerating the ...

MSD Merck Sharp & Dohme AG

Swissmedic grants approval for pembrolizumab (KEYTRUDA®) in combination with axitinib (Inlyta®) for first-line therapy of advanced renal cell carcinoma(1)

Lucerne (ots) - - Swissmedic approval is based on a significant benefit in overall survival with pembrolizumab in combination with axitinib compared to sunitinib in the Phase III study KEYNOTE-426 - Pembrolizumab is the first PD-1 inhibitor that has ...